CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis
NASDAQ:CCLDO - Nasdaq - US14167R3084 - Currency: USD
CCLDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. CCLDO has an excellent financial health rating, but there are some minor concerns on its profitability. CCLDO has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CCLDO had negative earnings in the past year.
CCLDO had a positive operating cash flow in the past year.
In the past 5 years CCLDO always reported negative net income.
Of the past 5 years CCLDO 4 years had a positive operating cash flow.
1.2 Ratios
CCLDO's Return On Assets of -4.40% is fine compared to the rest of the industry. CCLDO outperforms 72.97% of its industry peers.
CCLDO has a Return On Equity of -6.33%. This is in the better half of the industry: CCLDO outperforms 75.68% of its industry peers.
With an excellent Return On Invested Capital value of 14.75%, CCLDO belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.4% | ||
| ROE | -6.33% | ||
| ROIC | 14.75% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of CCLDO (8.77%) is better than 86.49% of its industry peers.
In the last couple of years the Operating Margin of CCLDO has grown nicely.
The Gross Margin of CCLDO (45.11%) is worse than 64.86% of its industry peers.
CCLDO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.77% | ||
| PM (TTM) | N/A | ||
| GM | 45.11% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCLDO is creating some value.
Compared to 1 year ago, CCLDO has more shares outstanding
The number of shares outstanding for CCLDO has been increased compared to 5 years ago.
Compared to 1 year ago, CCLDO has an improved debt to assets ratio.
2.2 Solvency
CCLDO has an Altman-Z score of 22.20. This indicates that CCLDO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 22.20, CCLDO belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
The Debt to FCF ratio of CCLDO is 0.03, which is an excellent value as it means it would take CCLDO, only 0.03 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.03, CCLDO belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
CCLDO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CCLDO has a Debt to Equity ratio of 0.00. This is in the better half of the industry: CCLDO outperforms 70.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 22.2 |
ROIC/WACC1.33
WACC11.07%
2.3 Liquidity
CCLDO has a Current Ratio of 1.27. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
CCLDO has a Current ratio (1.27) which is comparable to the rest of the industry.
CCLDO has a Quick Ratio of 1.24. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
CCLDO has a Quick ratio (1.24) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 85.92% over the past year.
CCLDO shows a decrease in Revenue. In the last year, the revenue decreased by -5.31%.
Measured over the past years, CCLDO shows a quite strong growth in Revenue. The Revenue has been growing by 11.47% on average per year.
EPS 1Y (TTM)85.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-5.31%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-0.62%
3.2 Future
Based on estimates for the next years, CCLDO will show a very strong growth in Earnings Per Share. The EPS will grow by 74.27% on average per year.
CCLDO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y157.8%
EPS Next 2Y74.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.38%
Revenue Next 2Y3.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCLDO. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 159.39, which means the current valuation is very expensive for CCLDO.
CCLDO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CCLDO is cheaper than 64.86% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCLDO to the average of the S&P500 Index (20.74), we can say CCLDO is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 159.39 |
4.2 Price Multiples
75.68% of the companies in the same industry are more expensive than CCLDO, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCLDO is valued a bit cheaper than the industry average as 64.86% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.91 | ||
| EV/EBITDA | 32.04 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 74.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.27%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCLDO has a Yearly Dividend Yield of 3.95%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 34.29, CCLDO pays a better dividend. On top of this CCLDO pays more dividend than 94.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.43, CCLDO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.95% |
5.2 History
The dividend of CCLDO is nicely growing with an annual growth rate of 21.20%!
CCLDO has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The dividend of CCLDO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP0%
EPS Next 2Y74.27%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (5/5/2025, 8:00:02 PM)
18.425
-0.04 (-0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.24%
Inst Owner ChangeN/A
Ins Owners37.42%
Ins Owner ChangeN/A
Market Cap779.75M
Analysts82
Price Target56.54 (206.87%)
Short Float %0.01%
Short Ratio0.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.95% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)85.74%
Min EPS beat(2)71.48%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)-23.2%
Min EPS beat(4)-357.52%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)-17.94%
EPS beat(12)8
Avg EPS beat(12)-3.5%
EPS beat(16)12
Avg EPS beat(16)5.11%
Revenue beat(2)0
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-1.89%
Max Revenue beat(2)-1.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)-1.1%
Revenue beat(8)0
Avg Revenue beat(8)-4.44%
Revenue beat(12)1
Avg Revenue beat(12)-3.54%
Revenue beat(16)3
Avg Revenue beat(16)-2.25%
PT rev (1m)0.56%
PT rev (3m)67.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)61.54%
EPS NY rev (1m)0%
EPS NY rev (3m)155.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 159.39 | ||
| P/S | 7.04 | ||
| P/FCF | 58.91 | ||
| P/OCF | 37.77 | ||
| P/B | 15.67 | ||
| P/tB | 65.58 | ||
| EV/EBITDA | 32.04 |
EPS(TTM)-0.2
EYN/A
EPS(NY)0.12
Fwd EY0.63%
FCF(TTM)0.31
FCFY1.7%
OCF(TTM)0.49
OCFY2.65%
SpS2.62
BVpS1.18
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.4% | ||
| ROE | -6.33% | ||
| ROCE | 18.67% | ||
| ROIC | 14.75% | ||
| ROICexc | 16.37% | ||
| ROICexgc | 85.25% | ||
| OM | 8.77% | ||
| PM (TTM) | N/A | ||
| GM | 45.11% | ||
| FCFM | 11.94% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 51.19% | ||
| Cap/Sales | 6.68% | ||
| Interest Coverage | 14.35 | ||
| Cash Conversion | 85.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 22.2 |
F-Score7
WACC11.07%
ROIC/WACC1.33
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y157.8%
EPS Next 2Y74.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.31%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-0.62%
Revenue Next Year1.38%
Revenue Next 2Y3.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y342.44%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year214.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y243.97%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y33.51%
OCF growth 3Y15.69%
OCF growth 5Y22.06%